DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 1 filers reported holding DYNE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 32.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,303 | -20.4% | 815,085 | 0.0% | 0.31% | +10.2% |
| Q2 2023 | $9,170 | +49.4% | 815,085 | +53.0% | 0.28% | -22.2% |
| Q1 2023 | $6,136 | +0.8% | 532,609 | +1.4% | 0.36% | +7.4% |
| Q4 2022 | $6,085 | -99.9% | 525,000 | 0.0% | 0.34% | +19.3% |
| Q3 2022 | $6,668,000 | +84.9% | 525,000 | 0.0% | 0.28% | +47.7% |
| Q2 2022 | $3,607,000 | -28.7% | 525,000 | 0.0% | 0.19% | -9.0% |
| Q1 2022 | $5,061,000 | -18.9% | 525,000 | 0.0% | 0.21% | +25.4% |
| Q4 2021 | $6,242,000 | -26.8% | 525,000 | 0.0% | 0.17% | -11.5% |
| Q3 2021 | $8,526,000 | -22.8% | 525,000 | 0.0% | 0.19% | -14.7% |
| Q2 2021 | $11,046,000 | +35.5% | 525,000 | 0.0% | 0.22% | +55.6% |
| Q1 2021 | $8,153,000 | +29.4% | 525,000 | +75.0% | 0.14% | +6.7% |
| Q4 2020 | $6,300,000 | -15.7% | 300,000 | -18.9% | 0.14% | -25.4% |
| Q3 2020 | $7,470,000 | – | 370,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $28,535,000 | 16.60% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $47,731,000 | 16.31% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $86,132,000 | 10.89% |
| Logos Global Management LP | 2,734,392 | $26,360,000 | 3.42% |
| Deep Track Capital, LP | 3,500,000 | $33,740,000 | 2.16% |
| Octagon Capital Advisors LP | 525,284 | $5,064,000 | 1.10% |
| HighVista Strategies LLC | 168,691 | $1,626,000 | 1.03% |
| Monashee Investment Management LLC | 279,704 | $2,696,000 | 0.78% |
| COMMODORE CAPITAL LP | 305,125 | $2,941,000 | 0.66% |
| RA Capital Management | 2,805,045 | $27,041,000 | 0.59% |